Home | News | Events | Contact Us | English | 繁體中文 | 日本語
About Us Product & Service Facilities Quality & Compliance For Investors Career
Latest Events
Latest News
Product & Service
BioTaiwan 2022, Taipei
July. 28-31, 2022
Booth no. R321
CPhI Worldwide, Frankfurt, Germany
Nov. 01-03, 2022
Formosa Injectable plant passed GMP/GDP inspection by TFDA.(Jun. 15, 2022) 2022-06-21
Formosa Pharmaceuticals and AimMax Therapeutics Announce Successful Top-Line Results from CPN-301 for the Treatment of Inflammation and Pain after Cataract Surgery 2022-05-13
Formosa Laboratories, Formosa Pharmaceuticals and HCmed Signed MoU to Form a Global CDMO for Inhalation Treatment Drugs 2022-03-07
Passed GDP inspection by TFDA for medicinal products. (Sep. 27th, 2021) 2021-11-11
Passed GMP inspection by TFDA for packaging and labeling of medicinal products. (Sep. 15th, 2021) 2021-11-11
Active Pharmaceutical Ingredients
Contract Development and Manufacturing Organization (CDMO)
Antibody Drug Conjugates (ADCs)
Injectable Manufacturing Services

Copyright ©2014 Formosa Laboratories, Inc. All Rights Reserved.